GetTopicDetailResponse(id=35c81131252, topicName=Marstacimab, introduction=Marstacimab, content=null, image=null, comments=1, allHits=1531, url=https://h5.medsci.cn/topic?id=11312, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=103613, tagList=[TagDto(tagId=103613, tagName=Marstacimab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2174272, encodeId=c92521e427235, content=<a href='/topic/show?id=bcd6889e9d5' target=_blank style='color:#2F92EE;'>#血友病#</a> <a href='/topic/show?id=35c81131252' target=_blank style='color:#2F92EE;'>#Marstacimab#</a>, objectTitle=新型血友病治療藥物III期臨床數(shù)據(jù)：相比常規(guī)預(yù)防治療和按需治療，Marstacimab 可使體內(nèi)不伴抑制物的血友病A及血友病B患者的年化出血率分別降低35%和92%, objectType=article, longId=804396, objectId=8415804396d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231211/1702278117058_92910.png, objectUrl=/article/show_article.do?id=8415804396d8, replyNumber=0, likeNumber=146, createdTime=2023-12-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8415804396d8, moduleTitle=新型血友病治療藥物III期臨床數(shù)據(jù)：相比常規(guī)預(yù)防治療和按需治療，Marstacimab 可使體內(nèi)不伴抑制物的血友病A及血友病B患者的年化出血率分別降低35%和92%, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8415804396d8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1581399, encodeId=ca28158139939, content=<a href='/topic/show?id=35c81131252' target=_blank style='color:#2F92EE;'>#Marstacimab#</a>, objectTitle=輝瑞TFPI抗體Marstacimab用于血友病治療，在國內(nèi)將開展臨床試驗, objectType=article, longId=194676, objectId=74451946e614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74451946e614, replyNumber=0, likeNumber=86, createdTime=2020-05-25, rootId=0, userName=12498bd5m21暫無昵稱, userId=0f8b16789719, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74451946e614, moduleTitle=輝瑞TFPI抗體Marstacimab用于血友病治療，在國內(nèi)將開展臨床試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=74451946e614)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
